Maraat, Reggie Ann B.

HRN: 25-33-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CEFTRIAXONE 1G (VIAL)
07/03/2024
07/12/2024
IVT
2g
Q12
T/c Meningitis
Waiting Final Action 
07/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2024
07/14/2024
IV
500mg
Q6
Bacterial Meningitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: